2026-01-12 - Analysis Report
**Company Overview:**
Tempus AI Inc is a technology company.

**Return Rate Comparison:**
- Return rate of review stock (TEM) = 17.23%
- Return rate of comparison stock (VOO) = 31.23%
- Divergence = -14.00 ($14.00 difference in cumulative return from the comparison stock on the last day of the data)

**Alpha, Beta Analysis:**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2024-2026  | 17.0% | 56.3% | -13.0% | 2.8 | 11.8B |

**Recent Stock Price Fluctuations:**
- Close: $66.27
- 5-day SMA: $67.73
- 20-day SMA: $65.60
- 60-day SMA: $74.49
- Last-market: $66.27, $68.36 (previous Close), -$3.06 (change)
  **Notice:** Fluctuation Issue - sharp decline.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence:**
- RSI: 58.19
- PPO: 1.35
- Hybrid Signal: Buy (Cash 0%): Risk Level - Medium (MRI 0.70)
- Recent (20 days) relative divergence change: 3.00 (+): improving
- 7-day Rank change: 0 (0): flat
- 7-day Dynamic Expected Return change: nan (0): flat
- Expected Return (%): N/A
- **Notice:** Fluctuation Issue - sharp decline.

**Recent News & Significant Events:**

- [2026-01-10] $TEM stock rose 6% this week. Here's what we see in our data. - Quiver Quantitative
- [2026-01-07] Is Tempus AI (TEM) Stock Price Reflecting Its Rapid 1â€‘Year Surge? - simplywall.st
- [2025-12-23] Tempus AI (TEM): Assessing Valuation After a Recent Share Price Pullback - Yahoo Finance
- [2026-01-09] Tempus AI Stock Surges 82.4% in a Year: What's Driving It? - Zacks Investment Research
- [2026-01-08] Ryan Fukushima Sells 5,000 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
- [2025-12-25] Why Tempus AI Stock Is Up 87% In 2025 - TIKR.com

**Analyst Opinions:**
- Analyst Consensus: Buy
- Mean (1=StrongBuy~5=Sell): 2.14
- Opinions: 12
- Target Price (avg/high/low): 87.92, 105.00, 76.00

**Comprehensive Analysis:**
- Return rate is lower than the comparison stock, but it's recovering.
- Divergence is improving, but it's still low.
- Fluctuation issue: sharp decline observed, sharp rebound in the recent news.
- Medium risk level as per MRI analysis.
- Analyst consensus is Buy with a moderate target price.
- Recent news and events highlight a significant price rise and analyst interest.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.